Contrary to this hypothesis, our results showed no detectable improvement in pancreatic β-cell function or other T2D-related blood markers including fasting and postprandial plasma glucose, insulin, and C-peptide, in either normoglycaemic or prediabetic individuals. This evidence concerns the gene INS and type 2 diabetes mellitus.